Company / Operating Cash Flow per Share
PROCEPT BioRobotics Corp Operating Cash Flow per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.90
FY2025
5-year range
-$10.26 / -$0.90
FY2021-FY2025
Trend
+54.2%
vs FY2024
Sector context
#150 of 161
Health Care
What the data says
Among 161 Health Care companies, PROCEPT BioRobotics Corp is in the bottom 7% for operating cash flow per share. Operating Cash Flow per Share has increased for 5 consecutive years, from $-13.20 in FY2020 to $-0.90 in FY2025.
Based on SEC 10-K filings.
-0.90 in FY2025.
Improved from $-2.13 to $-0.90 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 161This company -$0.90 Sector average $6.64
▼
-113.5% below sector average
Key checks
Key Insights
- PROCEPT BioRobotics Corp's operating cash flow per share has grown for 5 consecutive years.
- In FY2025, operating cash flow per share increased 54.2% year-over-year.
- Ranks #150 out of 161 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.90 | +54.2% |
| FY2024 | -$1.95 | +8.1% |
| FY2023 | -$2.13 | +38.9% |
| FY2022 | -$3.48 | +66.1% |
| FY2021 | -$10.26 | +22.3% |
| FY2020 | -$13.20 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026